| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CELA3B | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GLI3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | GIP | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | PACSIN2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | NUS1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | ARF4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | PTPA | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | FBXL6 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | HSPG2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | PATE3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
